American Association for Cancer Research
Browse
mct-21-0684_supplementary_data_s1_supps1.docx (1.29 MB)

Supplementary Data from Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis

Download (1.29 MB)
journal contribution
posted on 2023-04-03, 19:03 authored by Yi-Hsuan Wu, Zbigniew Gugala, Megan M. Barry, Yichao Shen, Subhamoy Dasgupta, Hai Wang
Supplementary Data from Optimization and Characterization of a Bone Culture Model to Study Prostate Cancer Bone Metastasis

Funding

Roswell Park Comprehensive Cancer Center

NCI

NIH

History

ARTICLE ABSTRACT

Nearly 90% of patients with advanced prostate cancer manifest bone metastases. Distinct from the osteolytic metastasis mostly observed in other cancer types, prostate cancer bone metastasis is typically more osteoblastic, which is relatively understudied due to the lack of reliable and efficient models to resemble the indolent cellular growth and complexity of metastatic progression. In our previous studies, we developed bone-in-culture array (BICA) to primarily model the osteoblast-involved, pre-osteolytic stage of breast cancer bone metastasis. Given that the progression of prostate cancer bone metastasis is largely osteoblastic, it is reasonable to speculate that the original BICA model can be adjusted to investigate prostate cancer bone metastases. In this study, we refined BICA by reducing the surgical labor and improving its reproducibility and capacity. The optimized BICA can successfully recapitulate important features of prostate cancer bone metastasis such as the osteoblastic phenotype, indolent growth, cancer–niche interactions, and response to hormones. Our efforts address the long-standing need for reliable and efficient models to study prostate cancer bone metastasis.

Usage metrics

    Molecular Cancer Therapeutics

    Categories

    Keywords

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC